Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
A review and update on melanocyte stimulating hormone therapy: afamelanotide.
[erythropoietic protoporphyria]
Afamelanotide
(
[
Nle
4
-
D-Phe
7
]
-
alpha-
MSH
)
is
an
analog
of
alpha-melanocyte
stimulating
hormone
given
as
a
subcutaneous
injection
.
Afamelanotide
is
currently
undergoing
phase
II
and
III
trials
in
Europe
and
the
US
for
skin
diseases
including
vitiligo
,
erythropoietic
protoporphyria
,
polymorphic
light
eruption
and
prevention
of
actinic
keratoses
in
organ
transplant
recipients
.
Unregulated
analogs
and
chemicals
are
being
sold
online
ahead
of
formal
approval
.
A
number
of
counterfeit
chemicals
,
'
Melanotans
'
are
being
sold
for
tanning
purposes
.
Currently
,
afamelanotide
is
already
on
the
market
in
Italy
and
Switzerland
for
patients
with
erythropoietic
protoporphyria
.
This
paper
will
review
the
current
literature
on
this
promising
compound
.
Diseases
Validation
Diseases presenting
"subcutaneous injection"
symptom
allergic bronchopulmonary aspergillosis
cutaneous mastocytosis
erythropoietic protoporphyria
esophageal carcinoma
esophageal squamous cell carcinoma
pendred syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom